b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31904557</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>20</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1878-7568</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>104</Volume>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>03</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Acta biomaterialia</Title>\n                <ISOAbbreviation>Acta Biomater</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Structural changes in lipid mesophases due to intercalation of dendritic polymer nanoparticles: Swollen lamellae, suppressed curvature, and augmented structural disorder.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>198-209</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S1742-7061(19)30879-7</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actbio.2019.12.036</ELocationID>\n            <Abstract>\n                <AbstractText>Understanding interactions between nanoparticles and model membranes is relevant to functional nano-composites and the fundamentals of nanotoxicity. In this study, the effect of polyamidoamine (PAMAM) dendrimers as model nanoparticles (NP) on the mesophase behaviour of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) has been investigated using high-pressure small-angle X-ray scattering (HP-SAXS). The pressure-temperature (p-T) diagrams for POPE mesophases in excess water were obtained in the absence and presence of G2 and G4 polyamidoamine (PAMAM) dendrimers (29\xc2\xa0\xc3\x85 and 45\xc2\xa0\xc3\x85 in diameter, respectively) at varying NP-lipid number ratio (\xce\xbd\xc2\xa0=\xc2\xa00.0002-0.02) over the pressure range p\xc2\xa0=\xc2\xa01-3000\xc2\xa0bar and temperature range T\xc2\xa0=\xc2\xa020-80\xc2\xa0\xc2\xb0C. The p-T phase diagram of POPE exhibited the L<sub>\xce\xb2</sub>, L<sub>\xce\xb1</sub> and H<sub>II</sub> phases. Complete analysis of the phase diagrams, including the relative area pervaded by different phases, phase transition temperatures (T<sub>t</sub>) and pressures (p<sub>t</sub>), the lattice parameters (d-spacing), the pressure-dependence of d-spacing (\xce\x94d/\xce\x94p), and the structural ordering in the mesophase as gauged by the Scherrer coherence length (L) permitted insights into the size- and concentration-dependent interactions between the dendrimers and the model membrane system. The addition of dendrimers changed the phase transition pressure and temperature and resulted in the emergence of highly swollen lamellar phases, dubbed L<sub>\xce\xb2-den</sub> and L<sub>\xce\xb1-den</sub>. G4 PAMAM dendrimers at the highest concentration \xce\xbd\xc2\xa0=\xc2\xa00.02 suppressed the formation of the H<sub>II</sub> phase within the temperature range studied, whereas the addition of G2 PAMAM dendrimers at the same concentration promoted an extended mixed lamellar region in which L<sub>\xce\xb1</sub> and L<sub>\xce\xb2</sub> phases coexisted. STATEMENT OF SIGNIFICANCE: Using high pressure small angle X-ray scattering in the pressure range 1-3000\xc2\xa0bar and temperature range 20-60\xc2\xa0\xc2\xb0C, we have studied interactions between PAMAM dendrimers (as model nanoparticles) and POPE lipid mesophases (as model membranes). We report the pressure-temperature phase diagrams for the dendrimer-lipid mesophases for the first time. We find that the dendrimers alter the phase transition temperatures (T<sub>t</sub>) and pressures (p<sub>t</sub>), the lattice parameters (d-spacing), and the structural order in the mesophase. We interpret these unprecedented results in terms of the fluidity of the lipid membranes and the interactions between the dendrimers and the membranes. Our findings are of fundamental relevance to the field of nanotoxicity and functional nanomaterials that integrate nanoparticles and organized lipid structures.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Fox</LastName>\n                    <ForeName>Laura J</ForeName>\n                    <Initials>LJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemistry, University of Bristol, Cantock\'s Close, Bristol, BS8 1TS, UK; Bristol Centre for Functional Nanomaterials, HH Wills Physics Laboratory, University of Bristol, Tyndall Avenue, Bristol, BS8 1TL, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Matthews</LastName>\n                    <ForeName>Lauren</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemistry, University of Bristol, Cantock\'s Close, Bristol, BS8 1TS, UK; Bristol Centre for Functional Nanomaterials, HH Wills Physics Laboratory, University of Bristol, Tyndall Avenue, Bristol, BS8 1TL, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Stockdale</LastName>\n                    <ForeName>Holly</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemistry, University of Bristol, Cantock\'s Close, Bristol, BS8 1TS, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pichai</LastName>\n                    <ForeName>Supakit</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemistry, University of Bristol, Cantock\'s Close, Bristol, BS8 1TS, UK; Bristol Centre for Functional Nanomaterials, HH Wills Physics Laboratory, University of Bristol, Tyndall Avenue, Bristol, BS8 1TL, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Snow</LastName>\n                    <ForeName>Tim</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Diamond Light Source, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0QX, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Richardson</LastName>\n                    <ForeName>Robert M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Physics, HH Wills Physics Laboratory, University of Bristol, Tyndall Avenue, Bristol, BS8 1TL, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Briscoe</LastName>\n                    <ForeName>Wuge H</ForeName>\n                    <Initials>WH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Chemistry, University of Bristol, Cantock\'s Close, Bristol, BS8 1TS, UK. Electronic address: wuge.briscoe@bristol.ac.uk.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>03</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Acta Biomater</MedlineTA>\n            <NlmUniqueID>101233144</NlmUniqueID>\n            <ISSNLinking>1742-7061</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Cellular uptake</Keyword>\n            <Keyword MajorTopicYN="Y">Endocytosis</Keyword>\n            <Keyword MajorTopicYN="Y">High-pressure small angle X-ray scattering</Keyword>\n            <Keyword MajorTopicYN="Y">Lipid mesophases</Keyword>\n            <Keyword MajorTopicYN="Y">Membrane models</Keyword>\n            <Keyword MajorTopicYN="Y">Nanoparticles</Keyword>\n            <Keyword MajorTopicYN="Y">Nanotoxicity</Keyword>\n            <Keyword MajorTopicYN="Y">PAMAM dendrimers</Keyword>\n            <Keyword MajorTopicYN="Y">Synchrotron scattering</Keyword>\n        </KeywordList>\n        <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31904557</ArticleId>\n            <ArticleId IdType="pii">S1742-7061(19)30879-7</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.actbio.2019.12.036</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'